Results

1–4 of 4 results for non-infectious uveitis

Comparison of Originator and Biosimilar Medications for Pediatric Noninfectious Uveitis
Nita Valikodath, MD, MS
Annual Meeting Talks
2023
Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
Post Hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis
Shree K. Kurup, MD
Annual Meeting Talks
2020
Course of Macular Edema Through 36 Months With Fluocinolone Acetonide Intravitreal Insert for Non-infectious Uveitis Affecting the Posterior Segment
Seenu M. Hariprasad, MD
Annual Meeting Talks
2020